Search Results

You are looking at 1 - 10 of 1,332 items for :

  • hypertension x
Clear All
Open access

Ingrid Prkacin, Petra Vrdoljak, Gordana Cavric, Damir Vazanic, Petra Pervan and Visnja-Nesek Adam

References 1. Vongpatanasin W. Resistant hypertension: a review of diagnosis and management. JAMA 2014; 311: 2216-2224. 2. Egan BM, Zhao Y, Axon RN, et al. Uncontrolled and Apparent Treatment Resistant Hypertension in the U.S. 1988-2008. Circulation 2011; 124(9): 1046-1058. doi: 10.1161/CIRCULATIONAHA.111.030189. 3. Sim JJ, Bhandari SK, Shi J, et al. Characteristics of Resistant Hypertension in a Large Ethnically Diverse Hypertension Population of an Integrated Health System. Mayo Clinic Proceedings 2013; 88

Open access

Joanna Rosiak, Beata Kubic-Filiks and Jolanta Szymanska

REFERENCES 1. Chavez E. et al: P-Wave Dispersion: a possible warning sign of hypertension in children. MEDICC Review , 16, 31, 2014. 2. Cintez E. et al.: Hypertension in Romanian children and adolescents: a cross-sectional survey. Maedica J. Ciln. Med. , 8, 5, 2013. 3. Costa J.V. et al.: An analysis of risk factor for arterial hypertension in adolescent students. Latino-Am. Enfermagem , 20, 289, 2012. 4. Denney-Wilson E. et al.: Body mass index, waist circumference, and chronic disease risk factors in Australian adolescents. Arch

Open access

Guo-Jun Yang

References 1. National Cardiovascular Disease Center. Chinese Cardiovascular Disease Report 2008-2009. Beijing: Encyclopedia of China Publishing House; 2010. p. 1. 2. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10. 3. Junga K, Merlo J, Gullberg B, Bog-Hansen E, Rastam L, Lindblad U. Residual risk for acute stroke in patients with type 2 diabetes and

Open access

Sasa Jacovic, Marija Zivkovic-Radojevic and Dejan Petrovic

References 1. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 2014; 35(19):1245-54. 2. Kallistratos MS, Giannakopoulos A, German V, Manolis AJ. Diagnostic Modalities of the Most Common Forms of Secondary Hypertension. Hellenic J Cardiol 2010; 51:518-29. 3. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: Why is it so resistant to treatment? Kidney Int 2006; 69(6):967-73. 4. Campese VM. Pathophysiology of

Open access

Helen Poser and Carlo Guglielmini

References 1. Stepien RL: Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs. J Small Anim Pract 2009, 50-SUPPL 1:34-43. 2. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB: Defi nitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013, 62(25 SUPPL):D42-D50. 3. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez

Open access

Olga Bulavenko and Oksana Vaskiv

References 1. Coonrod, D.V. et al.: Ethnicity, acculturation and obstetric outcomes. J. Reprod Med., 1, 49, 2004. 2. Kosova A.S. (2015). Preeclampsia: modern approaches for prediction and prevention. Autoabstract. Thesis candidate of medical science. Orel. 3. Ohapkyn M.B. at al.: Preeclampsia: hemodynamic adaptation syndrome. J. AG-info., 9, 3, 2002. 4. Pristrom A.M. (2011). Arterial hypertension of pregnant: diagnosis, classification, clinical forms. Medisont, Minsk. 5

Open access

Maria-Magdalena Roșu and Maria Moța

R eferences 1. Ford ES . Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 123(16): 1737-1744, 2011. 2. Menéndez E, Delgado E, Fernández-Vega F et al . Prevalence, Diagnosis, Treatment, and Control of Hypertension in Spain. Results of the Study. Rev Esp Cardiol (Engl Ed) 69(6): 572-578, 2016. 3. Chobanian AV, Bakris GL, Black HR et al . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of

Open access

Şuteu Carmen, Blesneac Cristina, Togănel Rodica and Benedek Theodora

References 1. Georg Hansmann, Marius M. Hoeper. Registries for paediatric pulmonary hypertension. Eur Respir J. 2013;42:580-583. 2. Fraisse A, Jais X, Schleich JM, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. 2010;103:66-74. 3. Modelina S, Hislop AA, Foster H, et al. Childhood idiopathic pulmonary arterial hypertension: a national cohort study. Heart. 2010;96:1401-1406. 4. von Loon RL, Roofthooft MT, Hillege HL, et al. Pediatric pulmonary

Open access

Srdjan Ljubisavljević and Jasna Zidverc Trajković

References 1. Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand 2010; 121 (2): 71-82. 2. Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 2012; 259 (5): 886-94. 3. Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology 2009; 72 (4): 304-9. http

Open access

Anna Ostoja-Chyżyńska, Piotr Kaliciński, Hor Ismail, Dorota Broniszczak, Małgorzata Markiewicz-Kijewska, Marek Szymczak, Wojciech Kwiatkowski and Jolanta Antoniewicz

References Sorof JM, Lai D, Turner J et al.: Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics 2004; 113: 475-82. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154-83. Falkner B, Sadowski RH : Hypertension in children and adolescens. Am J Hypertens 1995; 8: 106S-108S. Bartosh SM, Aronson AJ